Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 15 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

20%

3 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (8)
P 2 (4)
P 3 (3)

Trial Status

Completed8
Recruiting4
Unknown3

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07322965Not ApplicableRecruiting

Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma

NCT06526429Not ApplicableCompleted

Local Ischemic Postconditioning in Acute Ischemic Stroke

NCT04664946Not ApplicableRecruiting

Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With No Reperfusion Therapy (INSIST-NRT)

NCT06431113Phase 3Completed

Effect of Fixed Combination Citicoline Homotaurine and Pyrroloquinoline Quinone on Pattern-electroretinogram in Glaucoma

NCT04832412Not ApplicableCompleted

Effect of BrainPhyt, a Microalgae Based Ingredient on Cognitive Function in Healthy Older Subjects

NCT06545734Phase 2Recruiting

Effectiveness and Biological Mechanism of Direct Ischemic Post-conditioning for Acute Stroke Patients Due to Large Vessel Occlusion

NCT05128422Not ApplicableCompleted

Normobaric Hyperoxia Combined With Endovascular Treatment for Acute Ischemic Stroke

NCT04217421Phase 3Recruiting

Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass

NCT05404373Not ApplicableCompleted

Treatment Duration on Normobaric Hyperoxia in Acute Ischemic Stroke

NCT05674565Phase 2Unknown

Magnesium Sulphate Neuroprotective Strategies for Preterm Deliveries

NCT04681651Phase 2Completed

Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)

NCT05445505Not ApplicableUnknownPrimary

Neuroprotective Effects of iTBS in PD

NCT04554797Not ApplicableUnknown

Regional Hypothermia in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke

NCT00647998Phase 2Completed

The Darbepoetin Alfa for Ischemic Surgical Complications (DISC) Dose Finding Trial

NCT01759563Phase 3Completed

Oxygenation of the Cerebrum and Cooling During TAVI - Part I

Showing all 15 trials

Research Network

Activity Timeline